Primary lymphoma of the central nervous system: Epidemiology, pathology and current approaches to diagnosis, prognosis and treatment

Leukemia and Lymphoma

Volumn 49, Issue SUPPL. 1, 2008, Pages 43-51

  Rubenstein, James ^a   Ferreri, Andres J M ^b   Pittaluga, Stefania ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biomarkers; Epidemiology; PCNSL; Primary CNS lymphoma

Indexed keywords

BIOLOGICAL MARKER; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; METHOTREXATE; PROCARBAZINE; RITUXIMAB; TEMOZOLOMIDE; THIOTEPA; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BRAIN BIOPSY; BRAIN RADIATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURVIVAL; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG MEGADOSE; GENE EXPRESSION PROFILING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNOCOMPETENCE; LARGE CELL LYMPHOMA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NEUROTOXICITY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM NEOPLASMS; HUMANS; LYMPHOMA;

EID: 53249095570     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802311441     Document Type: Review

References (51)

1. Surawicz, T. S., McCarthy, B. J., Kupelian, V., Jukich, P. J., Bruner, J. M. and Davis, F. G. (1999) Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol, 1, pp. 14-25.
2. Ferreri, A. J., Abrey, L. E., Blay, J. Y., Borisch, B., Hochman, J. Neuwelt, E. A. et al. (2003) Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol, 21, pp. 2407-2414.
3. Makino, K., Nakamura, H., Kino, T., Takeshima, H. and Kuratsu, J. (2006) Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan. Surg Neurol, 66, pp. 503-506.
4. Haldorsen, I., Krossnes, B., Aarseth, J., Scheie, D., Johannesen, T., Mella, O. and Espeland, A. (2007) Increasing incidence and continued dismal outcome in primary central nervous system lymphoma in Norway 1989-2003, time trends in a 15-year national survey. Cancer, 110, pp. 1803-1814.
5. Olson, J. E., Janney, C. A., Rao, R. D., Cerhan, J. R., Kurtin, P. J. Schiff, D. et al. (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and end results analysis. Cancer, 95, pp. 1504-1510.
6. Schabet, M. (1999) Epidemiology of primary CNS lymphoma. J Neurooncol, 43, pp. 199-201.
7. Abrey, L. and Ferreri, A JM (2006) Primary and secondary central nervous system lymphomas in immunocompetent and human immunodeficiency virus-positive patients. Clinical Hematology,, pp. 564-578. Amsterdam, Netherlands: Elsevier
8. Wolf, T., Brodt, H. R. and Fichtlscherer, S. (2005) Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma, 46, pp. 207-215.
9. Biggar, R. J., Engels, E. A. and Ly, S. (2005) Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr, 39, pp. 293-299.
10. Bashir, R., Luka, J., Cheloha, K., Chamberlain, M. and Hochberg, F. (1993) Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology, 43, pp. 2358-2362.
11. Shen, D. F., Herbort, C. P., Tuaillon, N., Buggage, R. R., Egwuagu, C. E. and Chan, C. C. (2001) Detection of toxoplasma gondii DNA in primary intraocular B-cell lymphoma. Mod Pathol, 14, pp. 995-999.
12. Chan, C. C. (2003) Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc, 101, pp. 275-292.
13. Montesinos-Rongen, M., Hans, V. H., Eis-Hubinger, A. M., Prinz, M., Schaller, C. Van Roost, D. et al. (2001) Human herpes virus-8 is not associated with primary central nervous system lymphoma in HIV-negative patients. Acta Neuropathol, 102, pp. 489-495.
14. Corboy, J. R., Garl, P. J. and Kleinschmidt-DeMasters, B. K. (1998) Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology, 50, pp. 335-340.
15. Martini, F., Dolcetti, R., Ferreri, A. J., Ponzoni, M., Fumagalli, L. Reni, M. et al. (2004) No association between polyomaviruses and primary central nervous system lymphomas of HIV-seronegative and HIV-positive patients. Cancer Epidemiol Biomarkers Prev, 13, pp. 1819-1820.
16. Ferreri, A. J., Reni, M., Pasini, F., Calderoni, A., Tirelli, U. Pivnik, A. et al. (2002) A multicenter study of treatment of primary CNS lymphoma. Neurology, 58, pp. 1513-1520.
17. Bromberg, J EC, Siemers, M. D. and Taphoorn, M JB (2002) Is a "vanishing tumor" always a lymphoma?. Neurology, 59, pp. 762-764.
18. Soo, T. M., Bernstein, M., Provias, J., Tasker, R., Lozano, A. and Guha, A. (1995) Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg, 64, pp. 183-196.
19. Miller, D. C., Hochberg, F. H., Harris, N. L., Gruber, M. L., Louis, N. L. and Cohen, H. (1994) Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer, 74, pp. 1383-1397.
20. Grimm, S. A., Pulido, J. S., Jahnke, K., Schiff, D., Hall, A. J. Shenkier, T. N. et al. (2007) Primary intraocular lymphoma: An International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol, 18, pp. 1851-1855.
21. Antinori, A., De Rossi, G., Ammassari, A., Cingolani, A., Murri, R. Di Giuda, D et al. (1999) Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol, 17, pp. 554-560.
22. Abrey, L. E., Batchelor, T. T., Ferreri, A. J., Gospodarowicz, M., Pulczynski, E. J. Zucca, E. et al. (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol, 23, pp. 5034-5043.
23. Ferreri, A. J. and Reni, M. (2007) Primary central nervous system lymphoma. Crit Rev Oncol Hematol, 63, pp. 257-268.
24. Ferreri, A. J., Blay, J. Y., Reni, M., Pasini, F., Spina, M. Ambrosetti, A. et al. (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol, 21, pp. 266-272.
25. Ferreri, A JM, Blay, J. Y., Reni, M., Pasini, F., Gubkin, A. Tirelli, U. et al. (2002) Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ann Oncol, 13, pp. 531-538.
26. Chan, C. C., Buggage, R. R. and Nussenblatt, R. B. (2002) Intraocular lymphoma. Curr Opin Ophthalmol, 13, pp. 411-418.
27. Jahnke, K., Schilling, A., Heidenreich, J., Stein, H., Brock, M. Thiel, E. et al. (2005) Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients. Am J Neuroradiol, 26, pp. 2466-2454.
28. DeAngelis, L. M. and Ferreri, A JM (2007) Central nervous system lymphoma. Lymphoma: Pathology, Diagnosis and Treatment, p. pp. 200. Cambridge University Press, New York
29. Shenkier, T., Blay, J-Y, O'Neill, B., Poortmans, P. and Thiel, E. (2005) Primary CNS lymphoma of T-cell origin: A descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol, pp. 2233-2239.
30. Batchelor, T. and Loeffler, J. S. (2006) Primary CNS lymphoma. J Clin Oncol, 24, pp. 1281-1288.
31. Montesinos-Rongen, M., Van Roost, D., Schaller, C., Wiestler, O. D. and Deckert, M. (2004) Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood, 103, pp. 1869-1875.
32. Lin, C. H., Kuo, K. T., Chuang, S. S., Kuo, S. H., Chang, J. H. Chang, K. C. et al. (2006) Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphomas of central nervous system origin and peripheral nodal origin. Clin Cancer Res, 12, pp. 1152-1156.
33. Camilleri-Broët, S., Criniere, E., Broët, P., Delwail, V., Mokhtari, K. Moreau, A. et al. (2006) A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: Analysis of 83 cases. Blood, 107, pp. 190-196.
34. Rubenstein, J., Fridlyand, J., Shen, A., Aldape, K., Ginzinger, D. Batchelor, T. et al. (2006) Gene expression and angiotropism in primary CNS lymphoma. Blood, 107, pp. 3716-3723.
35. Kadoch, C., Treseler, P. and Rubenstein, J. (2006) Molecular pathogenesis of primary CNS lymphoma. Neurosurg Focus, 21, p. E1.
36. Tu, P. H., Giannini, C., Judkins, A. R., Schwalb, J. M., Burack, R. O'Neill, B. P. et al. (2005) Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: A primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol, 23, pp. 5718-5727.
37. Cheuk, W., Walford, N., Lou, J., Lee, A. K., Fung, C. F. Au, K. H. et al. (2001) Primary histiocytic lymphoma of the central nervous system: A neoplasm frequently overshadowed by a prominent inflammatory component. Am J Surg Pathol, 25, pp. 1372-1379.
38. Sun, W., Nordberg, M. L. and Fowler, M. R. (2003) Histiocytic sarcoma involving the central nervous system: Clinical, immunohistochemical, and molecular genetic studies of a case with review of the literature. Am J Surg Pathol, 27, pp. 258-265.
39. Abrey, L., Yahalom, J. and De Angelis, L. (2000) Treatment for primary CNS lymphoma: The next step. J Clin Oncol, 18, pp. 3144-3150.
40. Soussain, C., Suzan, F., Hoang-Xuan, K., Cassoux, N., Levy, V. Azar, N. et al. (2001) Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol, 19, pp. 742-749.
41. DeAngelis, L. M., Seiferheld, W., Schold, S. C., Fisher, B. and Schultz, C. J. (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol, 20, pp. 4643-4648.
42. Shah, G. D., Yahalom, J., Correa, D. D., Lai, R. K., Raizer, J. J. Schiff, D. et al. (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol, 25, pp. 4730-4735.
43. Ferreri, A. J., Dell'Oro, S., Foppoli, M., Bernardi, M., Brandes, A. A. Tosoni, A. et al. (2006) MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphoma. Neurology, 66, pp. 1435-1438.
44. Issa, M., Hwang, J., Karch, K., Fridlyand, M., Prados, T. Batchelor, K. et al. (2006) Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: A pilot study with biomarker analysis. J Clin Oncol, 24
45. Rubenstein, J. L., Combs, J., Rosenberg Levy, A, McDermott, M., Damon, L. Ignoffo, R. et al. (2003) Rituximab in CNS lymphoma: Targeting the leptomeningeal compartment. Blood, 101, pp. 466-468.
46. Rubenstein, J. L., Fridlyand, J., Abrey, L., Shen, A., Karch, J. Wang, E. et al. (2007) Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol, 25, pp. 1350-1356.
47. Barrans, S. L., Fenton, J. A., Banham, A., Owen, R. G. and Jack, A. S. (2004) Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood, 104, pp. 2933-2935.
48. Banham, A. H., Connors, J. M., Brown, P. J., Cordell, J. L., Ott, G. Sreenivasan, G. et al. (2005) Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res, 11, pp. 1065-1072.
49. Roy, S., Josephson, S. A., Fridlyand, J., Karch, J., Kadoch, C. Karrim, J. et al. (2008) Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol, 26, pp. 96-105.
50. Kadoch, C., Shuman, M. and Rubenstein, J. L. (2007) Complement activation and resistance within the cerebrospinal fluid following intraventricular administration of anti-CD20 in the treatment of central nervous system lymphoma. Blood, 110
51. Tun, H. W., Personett, D., Baskerville, K. A., Menke, D. M., Jaeckle, K. A. Kreinest, P. et al. (2008) Pathway analysis of primary central nervous system lymphoma. Blood, 111, pp. 3200-3210.